Remco specializes in helping life-sciences organizations develop global go-to-market and product lifecycle maximization strategies, addressing critical external stakeholder groups and leveraging internal functional expertise. He also serves as Putnam’s Boston Office Head. Since joining Putnam in 2000, Remco has served clients in the pharmaceutical, biotech and medical device industries on projects focused in both domestic
Eric advises life sciences clients in the areas of new product planning, launch planning, competitive strategy and pricing, reimbursement and market access. His clients include both leading and emerging manufacturers of innovative and established biopharmaceuticals, vaccines, medical devices, clinical diagnostics, and animal health products. Eric’s specialty is advising on competitive strategy, helping clients to evaluate
Matt serves leading clients within the life science industry on a range of commercial strategy issues. He has particular experience in helping his clients tackle complex challenges concerning pricing and market access strategy, product positioning and launch strategy, and market opportunity sizing and strategic direction setting. His practice is primarily focused in oncology, rare disease
Shauna is a finance executive with more than 20 years of professional experience and has held senior financial management positions in operational and corporate finance, with responsibility for: treasury management, financial planning and analysis, accounting and tax, regulatory compliance and business strategy and development. Shauna joined Putnam in 2019 as the firm’s Chief Financial Officer.
Jeri has more than 25 years of experience in various roles in the professional services industry, with a focus on talent and operations. Her passion lies in developing people strategies that propel organizations to the next level and creating vibrant, inclusive and productive work environments where employees can thrive. Jeri is the a voice that keeps
John has been with Putnam Associates since 1992, and has over 21 years of strategy consulting experience. John has counseled senior executives at numerous leading pharmaceutical and biotechnology companies, providing strategic support and recommendations on a wide array of issues, including pricing, contracting and reimbursement strategies, corporate strategy, new product commercialization, clinical trial development, and
Domenick advises biopharmaceutical, diagnostic, medical device, VC and private equity clients on new product strategies, therapeutic area strategies (including L&D), growth strategies, franchise strategic marketing, and pricing and market access. He specializes in studies that leverage quantitative analysis, deep understanding of healthcare stakeholders, and sophisticated modeling, often involving primary research. He has supported commercialization of
Paul advises biopharmaceutical and medical device clients on growth strategies, new product strategy, franchise strategic marketing, and pricing and reimbursement. He also serves as co-Chair of Putnam’s Talent Committee. During his consulting career, Paul has assisted pharmaceutical and biotechnology companies in business development, R&D strategy, product valuations, product launch planning, market assessments, forecasting and global
Scott Gilbert has served pharmaceutical and biotech clients across a wide range of specialty and primary care therapeutic areas in both domestic and international markets. Recent engagements have included pricing / managed markets strategy development, portfolio prioritization, medical adherence analysis, physician segmentation and opportunity analysis, and product forecasting. He has extensive expertise in advanced quantitative
Joseph serves major biopharmaceutical companies, developing strategies for pipeline agents, evaluating commercial opportunities, modeling detailed patient flows and treatment pathways, and optimizing plans for LCM/LOE. His clients span a wide range of therapeutic areas from oncology, cardiology, and hematology, to neurology and rheumatology, in addition to vaccines and diagnostics. Leveraging his experience with both pipeline
Ryan serves leading biopharmaceutical and early stage life-science companies in strategic areas related to commercial opportunity assessment, pricing and market access strategy, and strategic marketing at the franchise and product level. He has broad experience working across client functional groups including marketing, finance, and medical affairs, across geographies with his extensive work in the EU,
Sean is an experienced life sciences strategy consultant with expertise in global and US pricing & contracting strategy, competitive landscape assessment, revenue forecasting, M&A/licensing transactions, and portfolio strategy. He has a wealth of experience in specialty pharma and biotech markets including Oncology, Immunology, Endocrinology, Neuroscience, and Anti-infectives. Prior to joining Putnam, Sean was a research
Kristen has served pharmaceutical and biotechnology clients across a range of specialty therapeutic areas including neurology, dermatology, and immunology and has worked on engagements focused on market strategy development, product forecasting, and strategic brand planning. Prior to joining Putnam, Kristen worked in the medical technology industry where she specialized in market development strategies for stem cell-based
Alex has worked with a diverse global and start-up pharmaceutical, biotechnology, surgical device, and diagnostics clientele across product life cycle and functional areas including early-stage and in-line commercial, pricing and market access, and business analytics. Recent TA experience includes oncology (solid and hematological malignancies; targeted therapies, immuno-oncology, and CAR-T), benign hematology, allergy/immunology, respiratory medicine, autoimmune
I work with the partners, team, and clients to draw insights from primary and secondary data and provide strategies for supporting clinical and commercial development of pharmaceutical products.
My projects at Putnam dig deeply at the science of many of the biggest drugs, and then pivots into identifying or analyzing for business opportunities within the context of the science.
At Putnam, my role varies by project – but deep strategic analysis, laser focus on our clients’ goals, and sharp yet down-to-earth colleagues are all constants.
My role is exciting because it allows me to take on a wide range of different responsibilities from performing in-depth data analysis, to helping develop hypotheses and storylines for the overall project, to manage the workstreams of newer members of the team.
As a former bench scientist, I find it exciting to work on projects that involve cutting-edge technologies and breakthrough therapies that have a direct clinical impact. I am able to leverage my research expertise by providing scientific and analytical insight into the development of business strategies that help our clients tackle challenging problems.
At Putnam, I get to leverage my in-depth knowledge of life sciences and my business acumen to tackle exciting and challenging problems within the healthcare industry, while working alongside brilliant individuals with a passion for problem solving.
I feel fortunate for the opportunity that Putnam has afforded me to help solve intellectually stimulating problems related to innovative pharma therapies across a wide range of therapeutic areas. The hard and soft skills that Putnam allows you to build and hone right from the beginning are indispensable.
42% of Putnam employees have solved a Rubik’s cube
Putnam provides an incredible breadth of exposure to the challenges facing healthcare industry players, which our teams tackle with deep conceptual understanding and thoughtful problem structuring. Working alongside intelligent, hardworking colleagues drives both project success and individual growth.
Working at Putnam, we get to tackle the biopharma industry’s most exciting challenges. No two projects are alike, which means that our work is always stimulating and we never stop learning. I am continually impressed by my colleagues, who bring enthusiasm and passion to everything they do.
Putnam employees volunteer their time at over 24 different charitable organizations
Putnam is a fantastic place where everyone cares deeply about each other and the success of the team. As a Life Sciences Consultant, I’m often the scientific expert on my case team. I’ve leveraged my background experience and contributed from day one while learning new consulting and business skills.
Collectively, Putnam employees speak a total of 22 languages
Putnam allows me the opportunity to work with bright, talented individuals every day on solving problems for the leaders in the life science industry. I really enjoy working alongside professionals that push me and continue to help me develop in my career.
Every day at Putnam we immerse ourselves within the healthcare and business worlds in order to help tackle the challenges our clients are facing, providing unparalleled opportunities for professional growth. To be able to work with such motivated and intelligent colleagues makes engaging work even more rewarding.
At Putnam, I utilize my scientific background and critical thinking skills to help our teams provide meaningful solutions for our clients. It is extremely rewarding to team up with such high-caliber individuals to make an impact at the cutting-edge of the healthcare industry.
At Putnam, I’ve enjoyed working on a variety of global projects across multiple therapeutic areas within the life science industry. Small teams and mentors create a great culture with numerous opportunities to contribute, learn, and take on more responsibility.
92% of Putnam employees take Public transportation or walk to work
Putnam is a unique place where I have the opportunity to collaborate with wonderful colleagues and friends to help clients develop targeted and strategic insights. The company has a vibrant, supportive culture that has made coming to work every single day enjoyable and thought-provoking.
Putnam projects are intellectually stimulating and involve work alongside driven colleagues with innovative products in the rapidly evolving therapeutics landscape, creating an environment of constant learning and development.
Putnam has been the ideal balance between encouraging me to input my knowledge and strengths to improve certain processes and teaching me skills that will help me develop faster in my own career. I like that on any given day, I can learn something new and exciting from either my work or my peers.
91% of Putnam employees have worked on a case looking at global markets
Putnam provides me with the opportunity to tackle some of the most challenging strategic problems facing the healthcare industry today, doing so alongside incredibly talented colleagues.
Putnam Partners average 15 years of industry experience
It is extremely rewarding being part of a team of talented colleagues and partners who are invested in the growth and well-being of our clients. I enjoy facing exciting and interesting challenges with our capable team.
Putnam has served 19 of the top 20 global biopharmaceutical companies since 2010
I develop and promote best practices and standards for Putnam’s primary market research. I really enjoy working with our teams to find creative solutions to their research challenges.
Since 2000, more than 1/4 of Putnam Associates who have gone on to MBAs have attended HBS
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.